Literature DB >> 1972632

Verapamil and cyclosporin A sensitize human kidney tumor cells to vincristine in absence of membrane P-glycoprotein and without apparent changes in the cytoplasmic free Ca2+ concentration.

P Nygren1, R Larsson.   

Abstract

Vincristine (Vcr) dose dependently inhibited growth of the kidney adenocarcinoma cell line ACHN during 4 days of culture. Verapamil (Ver) at 10 microM and cyclosporin A (CsA) at 1 microgram/ml had no effect on cell growth but significantly potentiated the action of Vcr, despite the absence of the multidrug resistance associated membrane P-glycoprotein (P-gp). Neither Ver nor CsA had any acute or long term effects on cytoplasmic free Ca2+ concentration (Ca2+i), except for a small Ver induced increase after 36 h of incubation. The results indicate that Ver and CsA may have a sensitizing effect on chemotherapeutic drug sensitivity also in absence of P-gp. However, these effects are probably not mediated by changes in Ca2+i.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972632     DOI: 10.1007/bf01116583

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  7 in total

1.  Multidrug resistance increment in a human colon carcinoma cell line by colchicine.

Authors:  M J Ruiz Gómez; L Gil; A Souviron; M Martínez Morillo
Journal:  J Physiol Biochem       Date:  2000-03       Impact factor: 4.158

2.  Cytotoxic activity of topotecan in human tumour cell lines and primary cultures of human tumour cells from patients.

Authors:  E Jonsson; H Fridborg; K Csóka; S Dhar; C Sundström; P Nygren; R Larsson
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Doxorubicin selected multidrug-resistant small cell lung cancer cell lines characterised by elevated cytoplasmic Ca2+ and resistance modulation by verapamil in absence of P-glycoprotein overexpression.

Authors:  P Nygren; R Larsson; A Gruber; C Peterson; J Bergh
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

4.  Characterisation of a vindesine-resistant human small-cell lung cancer cell line.

Authors:  S Ohta; K Nishio; S Kubo; M Nishio; T Ohmori; T Takahashi; N Saijo
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

5.  Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance.

Authors:  S Dhar; P Nygren; K Csoka; J Botling; K Nilsson; R Larsson
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

6.  Comparison of the cytotoxic activity of melphalan with L-prolyl-m-L-sarcolysyl-L-p-fluorophenylalanine in human tumour cell lines and primary cultures of tumour cells from patients.

Authors:  R Larsson; S Dhar; H Ehrsson; P Nygren; R Lewensohn
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

7.  Detection of low-level expression of P-glycoprotein in ACHN renal adenocarcinoma cells.

Authors:  S Kawamoto; T Deguchi; S Nezasa; S Yamada; M Okano; Y Kawada
Journal:  Jpn J Cancer Res       Date:  1996-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.